Not Just Skin-Deep: Psoriasis, Part IIPremiere Date: Thursday, March 12, 2015
This activity offers CE credit for:%>
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, March 12, 2018
Note: Credit Is No Longer Available
|April W. Armstrong, MD, MPH
Vice Chair of Clinical Research
Associate Professor of Dermatology
Director, Clinical Trials and Outcomes Research
Director, Psoriasis Program
Department of Dermatology
Colorado Health Outcomes Program
University of Colorado Denver, School of Medicine
|Alan Menter, MD
Chief, Division of Dermatology
Baylor Scott & White
Clinical Professor of Periodontics
Baylor College of Dentistry
Clinical Professor of Dermatology
University of Texas Southwestern Medical Center
Co-Chair, Psoriasis Guidelines Committee for the American Academy of Dermatology
Dallas , TX
Patients with moderate-to-severe psoriasis are at risk for cardiovascular disorders and psoriatic arthritis. Dermatologists are in a unique position to screen for these disorders and counsel patients to be aware of early symptoms and risk factors. Prevention and early intervention of these disorders can be achieved by appropriate treatment of psoriasis and reduction of other risk factors contributing to these complications.1,2
In this medical simulation, you will meet Lisa, a 45-year-old woman who has questions about the effects of her skin condition on her overall health. Navigate this medical simulation and Lisa’s clinical challenges with Dr. Armstrong and Dr. Menter as your guides, to improve your knowledge of psoriasis comorbidities and clinical strategies to improve long-term patient outcomes.
- Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2008;58(5):826-850. PMID: 18423260.
- Kimball AB, Gladman D, Gelfand JM, et al; National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58(6):1031-1042. PMID: 18313171.
This educational activity centers on the CME Outfitters' Make One Change Statement. This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants. The Make One Change Statement for this activity is:
Screen and counsel more than 75% of patients with moderate-to-severe psoriasis for cardiovascular and psoriatic arthritis comorbidities.
At the end of this CE activity, participants should be able to:
- Implement treatment according to treatment guidelines in patients with moderate-to-severe psoriasis.
- Screen and counsel patients on comorbidities associated with psoriasis.
Supported by an educational grant from Celgene Corporation.
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Dermatologists, physicians, and other health care professionals, including pharmacists, nurses, physician assistants, and nurse practitioners, who have an interest in psoriasis.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hour.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-15-003-H01-P
Activity Type: application-based
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Armstrong has disclosed that she has received research and grant support from Amgen Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and Pfizer Inc. She serves as a consultant for AbbVie Inc.; Amgen Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.
Dr. Menter has no disclosures to report.
Erica Perilstein, MD (peer reviewer) has nothing to disclose.
Ruth Cody, MSN, RN-BC, CBN (peer reviewer) has nothing to disclose.
Frances Daniel, MPH (planning committee) has nothing to disclose.
Karen Roy, MSc., CCMEP (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).